Our Board


Phil Booth

Chief Strategy Officer

Phil joined BresMed in 2017 with 20 years’ experience in health economics, pricing and market access, gained in various country, regional and global roles across several pharmaceutical companies including Pfizer, Novartis, Sanofi and Amgen.

Phil has experience in applying health economics in development, launch and post-patent expiry. He has worked on numerous HTAs and reimbursement submissions across Europe.

Back to Our Board